Sign up to save your podcasts
Or
Share In conversation with...
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
In conversation with...
In conversation with... episodes
- Eosinophils and asthma: The Lancet Respiratory Medicine: November 2, 2015
David Price discusses a UK cohort study into the use of blood eosinophil count as a predictor of asthma exacerbations.
14 min - Bronchiolitis trial follow-up: The Lancet Respiratory Medicine: Aug 26, 2015
Håvard Skjerven and Karin Lødrup Carlsen discuss their follow-up study to the bronchiolitis ALL trial, which suggests that giving inhaled epinephrine for acute bronchiolitis in children does not confer benefit, even for those at risk of allergic disease.
7 min - The UPBEAT study: The Lancet Respiratory Medicine: July 22, 2015
Timothy Kidd discusses the results of a social network analysis to investigate the spread of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
14 min - COPD exacerbations: The Lancet Respiratory Medicine: July 10, 2015
Jose Luis Lopez-Campos discusses the heterogeneity of COPD exacerbations and proposes a new approach for treatment.
7 min - Pleural disease: The Lancet Respiratory Medicine: July 6, 2015
Nick Maskell and Najib Rahman discuss the pleural disease Series.
14 min - Life-support: The Lancet Respiratory: June 1, 2015
Jean-Louis Vincent, Lance Michell, and Pravin Amin discuss country-specific attitudes and approaches to the withdrawing of life-support.
34 min - GOLD 2007 and GOLD 2011: The Lancet Respiratory Medicine: May 18, 2015
Joan Soriano discusses the ability of the GOLD 2007 and 2011 staging systems to predict mortality.
8 min - Fibrotic interstitial lung diseases: The Lancet Respiratory Medicine: May 12, 2015
David Hansell discusses uses of serial CT in drug trials for IPF, and in clinical management of the disease.
8 min - Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: April 16, 2015
Michael Durheim discusses surrogate endpoints for trials in IPF.
7 min - Interleukin 5: The Lancet Respiratory Medicine: March 23, 2015
Targeting interleukin 5 for eosinophilic asthma – discussion with Jean Bousquet and Richard Lane.
5 min
About In conversation with...
From the publisher's feed
Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.